We illustrate a possible classification of HCC based on the tumour immune infiltration and give evidence about the role of SerpinB3, a serine protease inhibitor involved in the regulation of the immune response in different cancers. The gene discussed is SERPINB3; the disease is hepatocellular carcinoma.